STOCK TITAN

[144] INCYTE CORP SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Incyte Corporation (INCY) submitted a Form 144 notifying a proposed sale of 3,501 restricted shares valued at $299,464.34, to be executed through Morgan Stanley Smith Barney LLC on 10/03/2025 on NASDAQ. The shares were acquired as restricted stock from the issuer on 10/02/2025 and the filer reports 195,276,145 shares outstanding for the issuer.

The filing lists prior insider sales by Sheila Denton over the past three months totaling 6,165 shares across seven transactions, with gross proceeds shown for each sale (largest single prior sale: 3,330 shares for $232,633.80 on 07/15/2025). The notice includes the standard signature representation that the seller has no undisclosed material adverse information and names the executing broker and address.

Incyte Corporation (INCY) ha presentato un Form 144 notificando una prevista vendita di 3.501 azioni vincolate valutate 299.464,34 USD, da eseguire tramite Morgan Stanley Smith Barney LLC il 03/10/2025 su NASDAQ. Le azioni sono state acquisite come azioni vincolate dall'emittente il 02/10/2025 e il presentante riporta 195.276.145 azioni in circolazione per l'emittente. La presentazione elenca vendite interne precedenti da Sheila Denton negli ultimi tre mesi per un totale di 6.165 azioni attraverso sette transazioni, con l'attività lorda proveniente mostrata per ogni vendita (la singola vendita precedente più grande: 3.330 azioni per 232.633,80 USD il 15/07/2025). L'avviso include la consueta rappresentazione di firma secondo la quale il venditore non possiede informazioni materiali avverse non divulgate e nomina l'intermediario esecutore e l'indirizzo.

Incyte Corporation (INCY) presentó un Form 144 notificando una venta propuesta de 3,501 acciones restringidas por un valor de 299.464,34 USD, a realizarse a través de Morgan Stanley Smith Barney LLC el 03/10/2025 en NASDAQ. Las acciones fueron adquiridas como acciones restringidas por el emisor el 02/10/2025 y el declarante informa 195.276.145 acciones en circulación para el emisor. La presentación lista ventas internas previas por Sheila Denton durante los últimos tres meses por un total de 6.165 acciones repartidas en siete transacciones, con los ingresos brutos mostrados para cada venta (la mayor venta anterior individual: 3.330 acciones por $232.633,80 el 15/07/2025). El aviso incluye la representación de firma estándar de que el vendedor no posee información material adversa no divulgada y nombra al corredor ejecutante y la dirección.

Incyte Corporation (INCY) 는 NASDAQ에서 Morgan Stanley Smith Barney LLC 를 통해 3,501 주의 제한 주식의 제안된 매각을 통지하는 Form 144 를 제출했습니다. 주식은 발행사로부터 2025-10-02제한 주식으로 취득되었으며 신청자는 발행사의 유통 주식 수를 195,276,145 주로 보고합니다. 제출서는 지난 3개월 동안 Sheila Denton 의 내부자 매각을 총 6,165주로 열거하고 있으며, 7건의 거래에 걸쳐 각 매각에 대한 매출 총액이 표시되어 있습니다(가장 큰 단일 과거 매각: 3,330 주, $232,633.80, 2025-07-15). 공지에는 매도인이 비공개된 중요한 악재 정보를 보유하지 않으며 실행 중개인과 주소를 명시하는 표준 서명 진술이 포함되어 있습니다.

Incyte Corporation (INCY) a soumis un Form 144 notifiant une vente proposée de 3 501 actions restreintes d'une valeur de 299 464,34 USD, à réaliser par Morgan Stanley Smith Barney LLC le 03/10/2025 sur le NASDAQ. Les actions ont été acquises en tant qu’actions restreintes de l’émetteur le 02/10/2025 et le déclarant indique 195 276 145 actions en circulation pour l’émetteur. Le dépôt répertorie des ventes internes antérieures par Sheila Denton au cours des trois derniers mois pour un total de 6 165 actions réparties sur sept transactions, avec les produits bruts indiqués pour chaque vente (la plus grande vente précédente unique: 3 330 actions pour 232 633,80 USD le 15/07/2025). L’avis comprend la représentation de signature standard selon laquelle le vendeur n’a aucune information matérielle défavorable non divulguée et nomme le courtier exécutant et l’adresse.

Incyte Corporation (INCY) hat ein Form 144 eingereicht, das einen vorgeschlagenen Verkauf von 3.501 eingeschränkten Aktien im Wert von 299.464,34 USD mitteilt, der durch Morgan Stanley Smith Barney LLC am 03.10.2025 an der NASDAQ durchgeführt werden soll. Die Aktien wurden am 02.10.2025 als eingeschränkte Aktien des Emittenten erworben, und der Einreicher meldet 195.276.145 ausstehende Aktien des Emittenten. Die Einreichung listet frühere Insider-Verkäufe von Sheila Denton in den letzten drei Monaten auf insgesamt 6.165 Aktien in sieben Transaktionen, wobei der Bruttoerlös für jeden Verkauf angegeben wird (größter einzelner früherer Verkauf: 3.330 Aktien für 232.633,80 USD am 15.07.2025). Die Mitteilung enthält die übliche Signaturerklärung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt und benennt den ausführenden Broker und die Adresse.

Incyte Corporation (INCY) قدمت نموذج 144 يُشعر ببيع مقترح لـ 3,501 من الأسهم المقيدة بقيمة 299,464.34 دولارًا أمريكيًا، ليتم تنفيذه من خلال Morgan Stanley Smith Barney LLC في 03/10/2025 على NASDAQ. تم الحصول على الأسهم كـ أسهم مقيدة من المصدر في 02/10/2025 ويبلغ مقدم البلاغ عن 195,276,145 سهمًا قائمًا للمصدر. يدرج البيان عمليات بيع داخلية سابقة من Sheila Denton خلال الثلاثة أشهر الماضية بإجمالي 6,165 سهمًا عبر سبع معاملات، مع عرض العوائد الإجمالية لكل بيع (أكبر بيع سابق منفرد: 3,330 سهمًا مقابل 232,633.80 دولار في 15/07/2025). يتضمن الإشعار أيضًا بيان التوقيع القياسي بأن البائع لا يمتلك معلومات سلبية مادية غير مكتشفة ويذكر الوسيط المنفّذ وعنوانه.

Incyte Corporation (INCY) 已提交 Form 144,通知拟议出售 3,501 股受限股,价值为 299,464.34 美元,将通过 Morgan Stanley Smith Barney LLC2025-10-03 在 NASDAQ 执行。该等股票于 2025-10-02 作为发行方的受限股票获得,申报人报告发行方的流通在外股数为 195,276,145 股。该申报列出过去三个月由 Sheila Denton 的内部人前期出售,总计 6,165 股,共七笔交易,并列出每笔销售的毛收入(历史上单笔最大交易:3,330 股,$232,633.80,日期 2025-07-15)。通知还包括标准签名声明,表示卖方没有未披露的重大负面信息,并指明执行经纪商及地址。

Positive
  • Compliance with Rule 144 disclosed: broker, proposed sale date, and acquisition details are provided
  • Full transaction history for the past three months is listed, showing transparency of insider sales
Negative
  • Insider sale planned of 3,501 restricted shares valued at $299,464.34
  • Multiple recent insider disposals: 6,165 shares sold across seven transactions in the past three months

Insights

TL;DR: Insider intends to sell 3,501 restricted shares valued at $299,464.34, with multiple recent small insider sales disclosed.

This Form 144 documents a planned sale under Rule 144 using Morgan Stanley Smith Barney LLC and confirms the securities were issued as restricted stock on 10/02/2025. The filing fulfills disclosure requirements by listing the broker, proposed sale date 10/03/2025, and outstanding shares 195,276,145.

The record of seven prior sales by Sheila Denton in the past three months totaling 6,165 shares provides context on recent insider liquidity. This is factual reporting of transactions; the filing does not state any undisclosed material information or trading plan adoption date.

Incyte Corporation (INCY) ha presentato un Form 144 notificando una prevista vendita di 3.501 azioni vincolate valutate 299.464,34 USD, da eseguire tramite Morgan Stanley Smith Barney LLC il 03/10/2025 su NASDAQ. Le azioni sono state acquisite come azioni vincolate dall'emittente il 02/10/2025 e il presentante riporta 195.276.145 azioni in circolazione per l'emittente. La presentazione elenca vendite interne precedenti da Sheila Denton negli ultimi tre mesi per un totale di 6.165 azioni attraverso sette transazioni, con l'attività lorda proveniente mostrata per ogni vendita (la singola vendita precedente più grande: 3.330 azioni per 232.633,80 USD il 15/07/2025). L'avviso include la consueta rappresentazione di firma secondo la quale il venditore non possiede informazioni materiali avverse non divulgate e nomina l'intermediario esecutore e l'indirizzo.

Incyte Corporation (INCY) presentó un Form 144 notificando una venta propuesta de 3,501 acciones restringidas por un valor de 299.464,34 USD, a realizarse a través de Morgan Stanley Smith Barney LLC el 03/10/2025 en NASDAQ. Las acciones fueron adquiridas como acciones restringidas por el emisor el 02/10/2025 y el declarante informa 195.276.145 acciones en circulación para el emisor. La presentación lista ventas internas previas por Sheila Denton durante los últimos tres meses por un total de 6.165 acciones repartidas en siete transacciones, con los ingresos brutos mostrados para cada venta (la mayor venta anterior individual: 3.330 acciones por $232.633,80 el 15/07/2025). El aviso incluye la representación de firma estándar de que el vendedor no posee información material adversa no divulgada y nombra al corredor ejecutante y la dirección.

Incyte Corporation (INCY) 는 NASDAQ에서 Morgan Stanley Smith Barney LLC 를 통해 3,501 주의 제한 주식의 제안된 매각을 통지하는 Form 144 를 제출했습니다. 주식은 발행사로부터 2025-10-02제한 주식으로 취득되었으며 신청자는 발행사의 유통 주식 수를 195,276,145 주로 보고합니다. 제출서는 지난 3개월 동안 Sheila Denton 의 내부자 매각을 총 6,165주로 열거하고 있으며, 7건의 거래에 걸쳐 각 매각에 대한 매출 총액이 표시되어 있습니다(가장 큰 단일 과거 매각: 3,330 주, $232,633.80, 2025-07-15). 공지에는 매도인이 비공개된 중요한 악재 정보를 보유하지 않으며 실행 중개인과 주소를 명시하는 표준 서명 진술이 포함되어 있습니다.

Incyte Corporation (INCY) a soumis un Form 144 notifiant une vente proposée de 3 501 actions restreintes d'une valeur de 299 464,34 USD, à réaliser par Morgan Stanley Smith Barney LLC le 03/10/2025 sur le NASDAQ. Les actions ont été acquises en tant qu’actions restreintes de l’émetteur le 02/10/2025 et le déclarant indique 195 276 145 actions en circulation pour l’émetteur. Le dépôt répertorie des ventes internes antérieures par Sheila Denton au cours des trois derniers mois pour un total de 6 165 actions réparties sur sept transactions, avec les produits bruts indiqués pour chaque vente (la plus grande vente précédente unique: 3 330 actions pour 232 633,80 USD le 15/07/2025). L’avis comprend la représentation de signature standard selon laquelle le vendeur n’a aucune information matérielle défavorable non divulguée et nomme le courtier exécutant et l’adresse.

Incyte Corporation (INCY) hat ein Form 144 eingereicht, das einen vorgeschlagenen Verkauf von 3.501 eingeschränkten Aktien im Wert von 299.464,34 USD mitteilt, der durch Morgan Stanley Smith Barney LLC am 03.10.2025 an der NASDAQ durchgeführt werden soll. Die Aktien wurden am 02.10.2025 als eingeschränkte Aktien des Emittenten erworben, und der Einreicher meldet 195.276.145 ausstehende Aktien des Emittenten. Die Einreichung listet frühere Insider-Verkäufe von Sheila Denton in den letzten drei Monaten auf insgesamt 6.165 Aktien in sieben Transaktionen, wobei der Bruttoerlös für jeden Verkauf angegeben wird (größter einzelner früherer Verkauf: 3.330 Aktien für 232.633,80 USD am 15.07.2025). Die Mitteilung enthält die übliche Signaturerklärung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt und benennt den ausführenden Broker und die Adresse.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the INCY Form 144 disclose?

The filing discloses a proposed sale of 3,501 restricted shares valued at $299,464.34, to be executed on 10/03/2025 via Morgan Stanley Smith Barney LLC on NASDAQ.

When were the shares to be sold by INCY acquired?

The 3,501 shares were acquired as restricted stock from the issuer on 10/02/2025.

How many shares does INCY report outstanding in the filing?

The filing reports 195,276,145 shares outstanding for the issuer.

What recent insider sales does the INCY filing show?

It lists seven sales by Sheila Denton from 07/15/2025 to 10/02/2025, totaling 6,165 shares with individual gross proceeds reported.

Does the filing state any 10b5-1 plan adoption date?

No date of a Rule 10b5-1 plan adoption or instruction is provided in the filing.
Incyte Corp

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Latest SEC Filings

INCY Stock Data

17.03B
190.92M
2.03%
103.47%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON